Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
이종 및 동종 COVID-19 백신의 내구성 향상
Article
[키워드] Ad26
Ad26.COV2.S
Adenovirus
age
Analysis
Antibody Response
Antibody responses
Asian
assays
binding
black
BNT162b2
BNT162b2 vaccine
boost
Boston
CD4+ T-cell
CD8+
Cellular immune response
cellular immune responses
cohort study
COVID-19
COVID-19 vaccine
cytokine
Data analysis
declined
elicited
evaluate
evaluated
female
Follow-up
functional antibody response
Heterologous
heterologous prime-boost
Hispanic
homologous
humoral
humoral immune responses
immune response
immune responses
immunization
immunogenicity
individual
intracellular cytokine staining
involved
IQR
Latino
Massachusetts
median
Messenger RNA
mRNA
mRNA vaccine
Neutralizing
neutralizing antibodies titer
neutralizing antibody
occurred
of BNT162b2
omicron
outcome
participant
peaked
potential benefit
potential benefits
prime-boost regimen
rapid increase
regimen
repeated
response
SARS-CoV-2
SARS-CoV-2 variant
SARS-CoV-2 variants
T-cell responses
These data
Vaccine
was performed
were assessed
white
[DOI] 10.1001/jamanetworkopen.2022.26335 PMC 바로가기 [Article Type] Article
[DOI] 10.1001/jamanetworkopen.2022.26335 PMC 바로가기 [Article Type] Article